Facephi Biometria, S.A. (BME:FACE)
1.750
+0.005 (0.29%)
Aug 7, 2026, 12:56 PM CET
Facephi Biometria Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.35 | 11.47 | 2.73 | 4.34 | 1.7 |
Short-Term Investments | 0.45 | 0.36 | 0.17 | 0.31 | 0.04 |
Cash & Short-Term Investments | 4.79 | 11.83 | 2.9 | 4.66 | 1.74 |
Cash Growth | -59.48% | 307.65% | -37.65% | 167.32% | -73.19% |
Accounts Receivable | 22.74 | 18.73 | 13.56 | 11.2 | 8.01 |
Other Receivables | 2.01 | 3.75 | 1.87 | 1.9 | 0.43 |
Total Trade Receivables | 24.75 | 22.48 | 15.44 | 13.1 | 8.44 |
Inventory | 0.04 | 0 | - | - | - |
Other Current Assets | 0.98 | 0.68 | 0.77 | 0.45 | 0.3 |
Total Current Assets | 28.06 | 29.08 | 19.11 | 15.88 | 10.48 |
Net Property, Plant & Equipment | 1.97 | 2.36 | 2.65 | 1.81 | 0.42 |
Other Intangible Assets | 28.14 | 23.59 | 11.85 | 15.21 | 10.19 |
Long-Term Investments | 0 | 0.01 | 0 | - | 0 |
Other Long-Term Assets | 4.05 | 6.63 | 12.11 | 7.12 | 2.36 |
Total Assets | 47.98 | 49.71 | 45.71 | 32.25 | 18.36 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.55 | 9.96 | 3.78 | 0.57 | 0.42 |
Accrued Expenses | 4.93 | 5.56 | 1.14 | 0.34 | 0.56 |
Short-Term Debt | 8.54 | 11.32 | 10.07 | 7.22 | 1.39 |
Current Portion of Leases | 0 | 0.08 | 0.09 | 0.09 | 0 |
Unearned Revenue | 0.02 | 0.02 | - | - | - |
Other Current Liabilities | 0.49 | 2.05 | 7.32 | 4.52 | 2.13 |
Total Current Liabilities | 25.06 | 27.03 | 22.4 | 12.75 | 4.5 |
Long-Term Debt | 0.23 | 0.91 | 3.02 | 3.96 | 5.04 |
Long-Term Leases | 0.01 | 0.02 | - | 0.18 | 0 |
Other Long-Term Liabilities | 0.94 | 2.57 | 0.25 | 0.15 | 0.11 |
Total Long-Term Liabilities | 1.19 | 3.49 | 3.27 | 4.28 | 5.15 |
Total Liabilities | 26.24 | 30.52 | 25.67 | 17.04 | 9.65 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.13 | 2.03 | 0.85 | 1.39 | 1.21 |
Treasury Stock | -0.44 | -0.34 | -0.39 | -0.45 | -0.56 |
Additional Paid-in Capital | 34.51 | 32.44 | 24.23 | 15.56 | 10.07 |
Accumulated Other Comprehensive Income | 0.09 | 0.13 | 0.36 | 0.19 | 0.12 |
Retained Earnings | -18.18 | -19.78 | -5.1 | 12.38 | 6.05 |
Shareholders' Equity | 21.74 | 19.19 | 20.04 | 15.21 | 8.71 |
Total Liabilities & Equity | 47.98 | 49.71 | 45.71 | 32.25 | 18.36 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.79 | 12.33 | 13.19 | 11.45 | 6.44 |
Net Cash (Debt) | -4 | -0.49 | -10.28 | -6.79 | -4.69 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.15 | -0.02 | -0.48 | -0.39 | -0.33 |
Book Value | 21.74 | 19.19 | 20.04 | 15.21 | 8.71 |
Book Value Per Share | 0.82 | 0.76 | 0.94 | 0.87 | 0.61 |
Tangible Book Value | -6.4 | -4.4 | 8.2 | -0 | -1.48 |
Tangible Book Value Per Share | -0.24 | -0.17 | 0.38 | -0.00 | -0.10 |